SLYND (drospirenone)

SLYND (drospirenone)

SELF ADMINISTRATION - Oral

Indications for Prior Authorization: 

• Slynd® is a progestin indicated for use by females of reproductive potential to prevent pregnancy. 

Prior Authorization Criteria:

• Patient has tried and failed a preferred Norethindrone (progesterone only) contraceptive (e.g., Camila®, Errin®, Heather, Incassia®, Jencycla™) as confirmed by prior authorization documentation and/or paid prescription claims history. 

Dosing:

• One tablet is taken daily for 28 days (one white active tablet daily during the first 24 days and one green inert tablet daily during the 4 following days). 

Approval:

• 1 year